4.7 Review

Molecular pathways in dystonia

Journal

NEUROBIOLOGY OF DISEASE
Volume 42, Issue 2, Pages 136-147

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2010.11.015

Keywords

Dystonia; TorsinA; THAP1; PACT; PRKRA; Dopamine; Endoplasmic reticulum; Transcription; Stress

Categories

Funding

  1. NIH/NINDS [NS064450, NS069973, NS037409]
  2. Tyler's Hope for a Dystonia Cure, Inc.
  3. Dystonia Medical Research Foundation

Ask authors/readers for more resources

The hereditary dystonias comprise a set of diseases defined by a common constellation of motor deficits. These disorders are most likely associated with different molecular etiologies, many of which have yet to be elucidated. Here we discuss recent advances in three forms of hereditary dystonia, DYT1, DYT6 and DYT16, which share a similar clinical picture: onset in childhood or adolescence, progressive spread of symptoms with generalized involvement of body regions and a steady state affliction without treatment. Unlike DYT1, the genes responsible for DYT6 and DYT16 have only recently been identified, with relatively little information about the function of the encoded proteins. Nevertheless. recent data suggest that these proteins may fit together within interacting pathways involved in dopaminergic signaling, transcriptional regulation, and cellular stress responses. This review focuses on these molecular pathways, highlighting potential common themes among these dystonias which may serve as areas for future research. This article is part of a Special Issue entitled Advances in dystonia. (C) 2010 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available